| Bioactivity | Anti-osteoporosis agent-9 (compound 5b) 是一种 N-环丙基-4-((磺酰哌嗪-1-基)甲基)苯酰胺衍生物，显示出抗破骨细胞活性。 |
| Formula | C22H24F3N3O3S |
| Molar Mass | 467.50 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Marie Encarnacion A, et al. Novel inhibitor N-cyclopropyl-4-((4-((4-(trifluoromethyl)phenyl)sulfonyl)piperazin-1-yl)methyl)benzamide attenuates RANKL-mediated osteoclast differentiation in vitro. Bioorg Med Chem Lett. 2024;110:129884. |